China Quality Antibodies Anti -Dopamine CAS 62-31-7 Dopamine Hydrochloride Powder, Find details about China Dopamine, Dopamine Hydrochloride from Quality Antibodies Anti -Dopamine CAS 62-31-7 Dopamine Hydrochloride Powder
Description | Dopamine |
Protein full name | Sodium-dependent dopamine transporter |
Synonyms | DA transporter, DAT, Solute carrier family 6 member 3, Slc6a3, Dat, Dat1 |
Immunogen | Recombinant protein corresponding to Mouse Dopamine Transporter |
Purity | Affinity purification |
Dopamine, a sympathomimetic amine vasopressor, is the naturally occurring immediate precursor of norepinephrine. Dopamine hydrochloride is a white to off-white crystalline powder, which may have a slight odor of hy-drochloric acid. It is freely soluble in water and soluble in alcohol. Dopamine HCl is sensitive to alkalies, iron salts, and oxidizing agents. Chemically it is designated as 4-(2-aminoethyl) pyrocatechol hydrochloride, and the structural formula is:
Dopamine Hydrochloride Injection is a clear, practically colorless, sterile, pyrogen-free, aqueous solution of dopamine HCl for intravenous infusion after dilution. Each mL contains either 40 mg, 80 mg, or 160 mg of dopamine hydrochloride (equivalent to 32.3 mg, 64.6 mg and 129.2 mg of dopamine base respectively) in water for injection, q.s. Each mL of all preparations contains the following: sodium metabisulfite 9 mg added as an antioxidant; citric acid, anhydrous 10 mg and sodium citrate, dihydrate 5 mg added as a buffer. The pH range (2.5 to 5.0) may be adjusted with additional citric acid and/or sodium citrate.
Dopamine must be diluted in an appropriate sterile parenteral solution
PAIN KILLER | |
Benzocaine | 94-09-7 |
Benzocaine HCI | |
Lidocaine | 137-58-6 |
Lidocaine HCI | 73-78-9 |
Procaine | 59-46-1 |
Procaine HCI | 51-05-8 |
Prilocaine | 721-50-6 |
Prilocaine HCI | 1786-81-8 |
Tetracaine | 94-24-6 |
Tetracaine HCI | 136-47-0 |
Bupivacaine | 2180-92-9 |
Bupivacaine HCI | 14252-80-3 |
Levobupivacaine Hydrochloride | 27262-48-2 |
Pramoxine HCI | 637-58-1 |
Proparacaine HCI | 5875-06-9 |
Articaine HCI | 23964-57-0 |
Mepivacaine HCl | 1722-62-9 |
Ropivacaine HCI | 132112-35-7/98717-15-8 |
Dibucaine HCI | 61-12-1 |
Dopamine HCl is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure.
Patients most likely to respond adequately to dodpamine HCl are those in whom physiological parameters, such as urine flow, myocardial function, and blood pressure, have not undergone profound deterioration. Multiclinic trials indicate that the shorter the time interval between onset of signs and symptoms and initiation of therapy with volume correction and dopamine HCl, the better the prognosis. Where appropriate, blood volume restoration with a suitable plasma expander or whole blood should be accomplished or completed prior to administration of dopamine HCl.
SPECIFICATIONS | STANDARD BP2007 | RESULTS |
APPEARANCE | White or almost white powder | Conforms |
IDENTIFICATION | UV: similar to reference standard(285+/-2nm) IR: similar to the reference standard | Conforms |
RESIDE ON IGNITION | ≤0.1% | 0.03% |
HAEVY METALS | ≤20ppm | Conforms |
LOSS ON DRYING | ≤0.3% | 0.11% |
MELTING POINT | 164-168°C | 166-167°C |
5-Methylisoxazole-carboxylic acid | ≤0.1% | 0.06 |
Leflunomide related compound A | ≤0.01% | NONE |
Leflunomide related compound B | ≤0.3% | NONE |
N-(2'-Trifluoromethyphenyl)-5-methylisoxzole-4-carboxomide | ≤0.1% | NONE |
2-Cyano-acetic acid-(4'-trifluoromethyl)-anilide | ≤0.1% | NONE |
Leflunomide related compound C | ≤0.1% | 0.004 |
Total impuritie (excluding leflunomide related compound B and leflunomide related compound C ) | ≤0.2% | 0.1% |
Any other individual impurity | ≤0.1% | ≤0.1% |
Total impurities | ≤0.4% | 0.15% |
Assay | 98.0-102.0% | 99.84% |
PACKAGING AND STORAGE:Preserve in a well-closed container, store at a temperature not exceeding 30°C. | ||
CONCLUSION: THE PRODUCT CONFORMS TO BP2007 STANDARD. |
Hubei YYC Industrial Co., Ltd. is located in Wuhan Donghu High-Tech Economic Development Zone, specilize in production and exportation of pharmaceutical raw materials and intermediates, peptides, cosmetic ingredients, has invested and closed cooperated with domestic manufacturers and Laboratories from famous Universities to meet the different customers' needs from grams to tonnage quantity. We always stand in high starting, high stand and high quality, and masters strict management for production procedure and quality control. All the products must pass our quality test before being sending to customers.We have business with more than 60 countries, of which our main markets include Central and South America, Southeast Asia, Central Asia, Africa, Middle East, Eastern Europe, Russia and more and more higher regulative markets are being developed as long as our deep ploughing and weeding.
We have been working closely with customers, delivering products and solutions that create value and competitive advantage while positively impacting the world we live in, as well as attentive service for the purpose to meet the demand of customers, spare no effort to create value for customers. We sincerely welcome new and old customers home and abroad to contact us for future business relationships and mutual success!